Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $23.1400 (16.11%) ($20.1400 - $23.9400) on Thu. Sep. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.75% (three month average) | RSI | 67 | Latest Price | $23.1400(16.11%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(63%) IBB(63%) XBI(61%) IWO(58%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.375% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) UUP(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.375% (StdDev 4.75%) | Hourly BBV | 0 () | Intraday Trend | 11.9% | | | |
|
5 Day Moving Average | $21.47(7.78%) | 10 Day Moving Average | $21.74(6.44%) | 20 Day Moving Average | $21.1(9.67%) | To recent high | -0.1% | To recent low | 49.8% | Market Cap | $1.437b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |